INVIVYD, INC. Variable Lease, Cost
INVIVYD, INC. (IVVD) reported Variable Lease, Cost of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-13
- INVIVYD, INC. variable lease, cost for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- INVIVYD, INC. variable lease, cost for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- INVIVYD, INC. variable lease, cost for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- INVIVYD, INC. variable lease, cost for the quarter ending 2025-06-30 was $2.00K, a 50.00% decline year-over-year.
- INVIVYD, INC. variable lease, cost for fiscal 2025 was $6.00K, a 57.14% decline from fiscal 2024.
- INVIVYD, INC. variable lease, cost for fiscal 2024 was $14.00K, a 69.57% decline from fiscal 2023.
- INVIVYD, INC. variable lease, cost for fiscal 2023 was $46.00K, a 48.39% increase from fiscal 2022.
- INVIVYD, INC. variable lease, cost for fiscal 2022 was $31.00K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | ||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | $2.00K derived: sum of 3 quarters · filed 2026-08-13 | $6.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | $2.00K derived: sum of 2 quarters · filed 2026-08-13 | $6.00K 10-Q · filed 2025-11-06 | $10.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $2.00K 10-Q · filed 2026-08-13 | $6.00K 10-Q · filed 2026-08-13 | $10.00K derived: sum of 3 quarters · filed 2026-08-13 | $14.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $5.00K 10-Q · filed 2026-05-14 | $8.00K derived: sum of 2 quarters · filed 2026-05-14 | $12.00K derived: sum of 3 quarters · filed 2026-05-14 | $16.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $7.00K derived: sum of 2 quarters · filed 2026-03-05 | $11.00K derived: sum of 3 quarters · filed 2026-03-05 | $14.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $4.00K 10-Q · filed 2025-11-06 | $8.00K derived: sum of 2 quarters · filed 2025-11-06 | $11.00K 10-Q · filed 2025-11-06 | $23.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $4.00K 10-Q · filed 2025-08-14 | $7.00K 10-Q · filed 2025-08-14 | $19.00K derived: sum of 3 quarters · filed 2025-08-14 | $30.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $3.00K 10-Q · filed 2025-05-15 | $15.00K derived: sum of 2 quarters · filed 2025-05-15 | $26.00K derived: sum of 3 quarters · filed 2025-05-15 | $37.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $23.00K derived: sum of 2 quarters · filed 2025-03-20 | $34.00K derived: sum of 3 quarters · filed 2025-03-20 | $46.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $11.00K 10-Q · filed 2024-11-14 | $22.00K derived: sum of 2 quarters · filed 2024-11-14 | $34.00K 10-Q · filed 2024-11-14 | $41.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $11.00K 10-Q · filed 2024-08-14 | $23.00K 10-Q · filed 2024-08-14 | $30.00K derived: sum of 3 quarters · filed 2024-08-14 | $38.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $12.00K 10-Q · filed 2024-05-09 | $19.00K derived: sum of 2 quarters · filed 2024-05-09 | $27.00K derived: sum of 3 quarters · filed 2024-05-09 | $35.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $15.00K derived: sum of 2 quarters · filed 2024-03-28 | $23.00K derived: sum of 3 quarters · filed 2024-03-28 | $31.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $8.00K 10-Q · filed 2023-11-09 | $16.00K derived: sum of 2 quarters · filed 2023-11-09 | $24.00K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $8.00K 10-Q · filed 2023-08-10 | $16.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $8.00K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |